KBG Past Earnings Performance

Past criteria checks 4/6

KBG has been growing earnings at an average annual rate of 35%, while the Chemicals industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 4.9% per year. KBG's return on equity is 10.8%, and it has net margins of 20.4%.

Key information

35.0%

Earnings growth rate

35.6%

EPS growth rate

Chemicals Industry Growth13.9%
Revenue growth rate4.9%
Return on equity10.8%
Net Margin20.4%
Last Earnings Update30 Jun 2024

Recent past performance updates

We Think That There Are Some Issues For KBG (KOSDAQ:318000) Beyond Its Promising Earnings

May 21
We Think That There Are Some Issues For KBG (KOSDAQ:318000) Beyond Its Promising Earnings

Recent updates

The Market Doesn't Like What It Sees From KBG Corp.'s (KOSDAQ:318000) Earnings Yet As Shares Tumble 29%

Aug 06
The Market Doesn't Like What It Sees From KBG Corp.'s (KOSDAQ:318000) Earnings Yet As Shares Tumble 29%

We Think That There Are Some Issues For KBG (KOSDAQ:318000) Beyond Its Promising Earnings

May 21
We Think That There Are Some Issues For KBG (KOSDAQ:318000) Beyond Its Promising Earnings

If You Had Bought Korea Bio-GenLtd (KOSDAQ:318000) Stock A Year Ago, You Could Pocket A 33% Gain Today

Mar 02
If You Had Bought Korea Bio-GenLtd (KOSDAQ:318000) Stock A Year Ago, You Could Pocket A 33% Gain Today

The Trends At Korea Bio-GenLtd (KOSDAQ:318000) That You Should Know About

Feb 03
The Trends At Korea Bio-GenLtd (KOSDAQ:318000) That You Should Know About

Should You Be Impressed By Korea Bio-Gen Co.,Ltd's (KOSDAQ:318000) ROE?

Dec 29
Should You Be Impressed By Korea Bio-Gen Co.,Ltd's (KOSDAQ:318000) ROE?

Calculating The Intrinsic Value Of Korea Bio-Gen Co.,Ltd (KOSDAQ:318000)

Dec 02
Calculating The Intrinsic Value Of Korea Bio-Gen Co.,Ltd (KOSDAQ:318000)

Revenue & Expenses Breakdown

How KBG makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A318000 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2423,2044,7362,075993
31 Mar 2422,3825,0051,941883
31 Dec 2321,5894,5831,907837
30 Sep 2322,1663,6711,907820
30 Jun 2322,9983,8411,894829
31 Mar 2323,7522,9761,957871
31 Dec 2224,3463,2521,9521,072
30 Sep 2226,8974,4872,0151,150
30 Jun 2227,5254,0542,0041,248
31 Mar 2227,3984,2461,9071,373
31 Dec 2127,2014,0041,8401,182
30 Sep 2124,5304,0381,7161,099
30 Jun 2123,1384,0591,6271,093
31 Mar 2120,7653,3311,5611,023
31 Dec 2019,7883,1231,443977
30 Sep 2019,4283,0511,347867
30 Jun 2018,408-1,3551,351796
31 Mar 2019,152-1,2231,324765
31 Dec 1918,526-1,4051,278718
30 Sep 1918,348-1,9321,241565
31 Mar 1917,3632,2301,067869
31 Dec 1816,4342,130971850
31 Dec 1714,4061,641933959
31 Dec 1613,1321,561806894
31 Dec 1512,9891,260873609
31 Dec 1412,628897724651
31 Dec 1315,1071,410729516

Quality Earnings: A318000 has high quality earnings.

Growing Profit Margin: A318000's current net profit margins (20.4%) are higher than last year (16.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A318000's earnings have grown significantly by 35% per year over the past 5 years.

Accelerating Growth: A318000's earnings growth over the past year (23.3%) is below its 5-year average (35% per year).

Earnings vs Industry: A318000 earnings growth over the past year (23.3%) exceeded the Chemicals industry -4.5%.


Return on Equity

High ROE: A318000's Return on Equity (10.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies